Liver biopsy remains an important clinical diagnostic tool,3 but there is a clear obligation to extract as much information from biopsy material as possible, given the associated risks.1 The data provide encouragement to examine elastin in large, prospective cohorts of advanced liver fibrosis patients with continuing liver injury. The gene discussed is ELN; the disease is Hepatic fibrosis.